Ensartinib hydrochloride capsules can treat small cell lung cancer. When using the drug, patients must use it reasonably according to the doctor’s instructions and cannot use it privately or blindly.
This is a common drug for the treatment of non-small cell lung cancer. The main working principle of the drug is that after entering the body, it inhibits the growth of tumor cells, which is beneficial to assist in improving the symptoms of small cell lung cancer, effectively controlling the development of the disease, improving the quality of life of patients, and delaying the survival time of patients.
Let us work together to protect precious health